63 related articles for article (PubMed ID: 26914296)
1. Ethnic counts on mortality, New Zealand Cancer Registry and census data: 2006-2011.
Boyd M; Blakely T; Atkinson J
N Z Med J; 2016 Jan; 129(1429):22-39. PubMed ID: 26914296
[TBL] [Abstract][Full Text] [Related]
2. Intravenous magnesium sulphate as an adjuvant therapy in acute exacerbations of chronic obstructive pulmonary disease: a single centre, randomised, double-blinded, parallel group, placebo-controlled trial: a pilot study.
Mukerji S; Shahpuri B; Clayton-Smith B; Smith N; Armstrong P; Hardy M; Marchant G; Marsh E
N Z Med J; 2015 Nov; 128(1425):34-42. PubMed ID: 26905985
[TBL] [Abstract][Full Text] [Related]
3. Use of nebulised magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in adults: a randomised double-blind placebo-controlled trial.
Edwards L; Shirtcliffe P; Wadsworth K; Healy B; Jefferies S; Weatherall M; Beasley R;
Thorax; 2013 Apr; 68(4):338-43. PubMed ID: 23299960
[TBL] [Abstract][Full Text] [Related]
4. Unlocking the numerator-denominator bias III: adjustment ratios by ethnicity for 1981-1999 mortality data. The New Zealand Census-Mortality Study.
Ajwani S; Blakely T; Robson B; Atkinson J; Kiro C
N Z Med J; 2003 Jun; 116(1175):U456. PubMed ID: 12838352
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of acute rheumatic fever in New Zealand 1996-2005.
Jaine R; Baker M; Venugopal K
J Paediatr Child Health; 2008 Oct; 44(10):564-71. PubMed ID: 19012628
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of intravenous magnesium sulphate as an adjunct to standard therapy in acute severe asthma.
Singh AK; Gaur S; Kumar R
Iran J Allergy Asthma Immunol; 2008 Dec; 7(4):221-9. PubMed ID: 19052352
[TBL] [Abstract][Full Text] [Related]
7. Widening ethnic mortality disparities in New Zealand 1981-99.
Blakely T; Tobias M; Robson B; Ajwani S; Bonné M; Woodward A
Soc Sci Med; 2005 Nov; 61(10):2233-51. PubMed ID: 16005132
[TBL] [Abstract][Full Text] [Related]
8. The burden of cancer in New Zealand: a comparison of incidence and DALY metrics and its relevance for ethnic disparities.
Costilla R; Tobias M; Blakely T
Aust N Z J Public Health; 2013 Jun; 37(3):218-25. PubMed ID: 23731103
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis epidemiology in New Zealand: 1995-2004.
Das D; Baker M; Calder L
N Z Med J; 2006 Oct; 119(1243):U2249. PubMed ID: 17063189
[TBL] [Abstract][Full Text] [Related]
10. Does mortality vary between pacific groups in New Zealand? Estimating Samoan, Cook Island Maori, Tongan, and Niuean mortality rates using hierarchical Bayesian modelling.
Blakely T; Richardson K; Young J; Callister P; Didham R
N Z Med J; 2009 Dec; 122(1307):18-29. PubMed ID: 20148041
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cancer mortality and incidence in New Zealand and Australia.
Skegg DC; McCredie MR
N Z Med J; 2002 May; 115(1153):205-8. PubMed ID: 12064704
[TBL] [Abstract][Full Text] [Related]
12. Ethnic inequalities in cancer survival in New Zealand: linkage study.
Jeffreys M; Stevanovic V; Tobias M; Lewis C; Ellison-Loschmann L; Pearce N; Blakely T
Am J Public Health; 2005 May; 95(5):834-7. PubMed ID: 15855462
[TBL] [Abstract][Full Text] [Related]
13. Ethnic counts on mortality and census data 2001-06: New Zealand census-mortality study update.
Tan L; Blakely T; Atkinson J
N Z Med J; 2010 Aug; 123(1320):37-44. PubMed ID: 20720601
[TBL] [Abstract][Full Text] [Related]
14. Hospital admissions for non-cystic fibrosis bronchiectasis in New Zealand.
Bibby S; Milne R; Beasley R
N Z Med J; 2015 Sep; 128(1421):30-8. PubMed ID: 26370753
[TBL] [Abstract][Full Text] [Related]
15. Patterns of presentation to the Australian and New Zealand Paediatric Emergency Research Network.
Acworth J; Babl F; Borland M; Ngo P; Krieser D; Schutz J; Pitt R; Cotterell E; Jamison S; Neutze J; Lee M
Emerg Med Australas; 2009 Feb; 21(1):59-66. PubMed ID: 19254314
[TBL] [Abstract][Full Text] [Related]
16. How much does health care contribute to health gain and to health inequality? Trends in amenable mortality in New Zealand 1981-2004.
Tobias M; Yeh LC
Aust N Z J Public Health; 2009 Feb; 33(1):70-8. PubMed ID: 19236363
[TBL] [Abstract][Full Text] [Related]
17. Unlocking the numerator-denominator bias. II: Adjustments to mortality rates by ethnicity and deprivation during 1991-94. The New Zealand Census-Mortality Study.
Blakely T; Kiro C; Woodward A
N Z Med J; 2002 Feb; 115(1147):43-8. PubMed ID: 11942514
[TBL] [Abstract][Full Text] [Related]
18. Unlocking the numerator-denominator bias. I: Adjustments ratios by ethnicity for 1991-94 mortality data. The New Zealand Census-Mortality Study.
Blakely T; Robson B; Atkinson J; Sporle A; Kiro C
N Z Med J; 2002 Feb; 115(1147):39-43. PubMed ID: 11942513
[TBL] [Abstract][Full Text] [Related]
19. Gout in Aotearoa New Zealand: are we going to ignore this for another 3 years?
Dalbeth N; Gow P; Jackson G; Shuker C; Te Karu L; Gerard C; Winnard D
N Z Med J; 2016 Jan; 129(1429):10-3. PubMed ID: 26914294
[No Abstract] [Full Text] [Related]
20. Community inequality and smoking cessation in New Zealand, 1981-2006.
Barnett R; Pearce J; Moon G
Soc Sci Med; 2009 Mar; 68(5):876-84. PubMed ID: 19136183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
